Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIc Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Not applicableStudy completedNCT01460875
What this trial is testing

Recombinant Interferon Alfa-2b in Treating Patients With Melanoma

Who this might be right for
Stage IA Skin MelanomaStage IB Skin MelanomaStage IIA Skin Melanoma+6 more
William Carson 34
Testing effectiveness (Phase 2)Study completedNCT02296112
What this trial is testing

Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations

Who this might be right for
Recurrent MelanomaStage IIIB MelanomaStage IIIC Melanoma+1 more
Vanderbilt-Ingram Cancer Center 9
Early research (Phase 1)Ended earlyNCT03727789
What this trial is testing

CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma

Who this might be right for
Advanced Cutaneous Melanoma of the ExtremityAdvanced Sarcoma of the ExtremityClinical Stage III Cutaneous Melanoma AJCC v8+10 more
Roswell Park Cancer Institute 7
Not applicableStudy completedNCT02857374
What this trial is testing

Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy

Who this might be right for
Stage IB Skin MelanomaStage IIA Skin MelanomaStage IIB Skin Melanoma+4 more
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02068586
What this trial is testing

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+9 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 210
Testing effectiveness (Phase 2)UnknownNCT00489944
What this trial is testing

Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma

Who this might be right for
Intraocular Melanoma
San Diego Pacific Oncology & Hematology Associates 50
Testing effectiveness (Phase 2)Ended earlyNCT04221438
What this trial is testing

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Who this might be right for
Melanoma of Unknown PrimaryMetastatic Malignant Neoplasm in Lymph NodePathologic Stage IIIB Cutaneous Melanoma AJCC v8+3 more
ECOG-ACRIN Cancer Research Group 3
Testing effectiveness (Phase 2)Study completedNCT00289016
What this trial is testing

Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma

Who this might be right for
Melanoma
BioVex Limited 50
Testing effectiveness (Phase 2)Ended earlyNCT02203604
What this trial is testing

High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
CINJRegulatory 9
Testing effectiveness (Phase 2)Study completedNCT01227551
What this trial is testing

Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

Who this might be right for
Malignant Melanoma
Viralytics 57
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Not applicableStudy completedNCT03707574
What this trial is testing

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Who this might be right for
Advanced Malignant NeoplasmAdvanced MelanomaAdvanced Renal Cell Carcinoma+51 more
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Not applicableUnknownNCT00897481
What this trial is testing

Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy

Who this might be right for
Melanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 1,000
Not applicableStudy completedNCT00897546
What this trial is testing

Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 1,716
Testing effectiveness (Phase 2)Ended earlyNCT01586195
What this trial is testing

Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E

Who this might be right for
Malignant Melanoma
Genentech, Inc. 31
Early research (Phase 1)Study completedNCT00471471
What this trial is testing

Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Intraocular MelanomaMalignant Conjunctival NeoplasmMelanoma (Skin)
Ahmad Tarhini 22
Testing effectiveness (Phase 2)WithdrawnNCT03220009
What this trial is testing

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Who this might be right for
Cervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT01026324
What this trial is testing

Dinaciclib in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Stage IIIB MelanomaStage IIIC MelanomaStage IV Melanoma
National Cancer Institute (NCI) 12
Next Page